TVTX
Travere Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$50.49
+1.79%Leverage
- Debt / equity
- 25.16x
- Net debt / equity
- 20.36x
- Debt / assets
- 0.77x
- Debt / EBITDA
- 106.77x
- Net debt / EBITDA
- 86.39x
Liquidity & coverage
- Current ratio
- 4.05x
- Quick ratio
- 3.99x
- Cash ratio
- 3.22x
- Interest coverage
- -4.27x
- EBITDA / interest
- 0.61x
- Working capital
- $463.1M
Cash & dividend
- FCF / debt
- 0.08x
- Cash flow / debt
- 0.15x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026